Delivery Order 75N92020D00022-75N92020F00001

Award Date 9/3/20
Potential Completion Date 9/2/25
Potential Value $229K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and bioinformatics products. The $131,931.29 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related goods and services to support genomic research and analysis. This award is not associated with a set-aside...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $246,062.25 contract is for the provision of sequencing systems, reagents, consumables, and related services to support genomic research and diagnostics. Illumina has previously received prime federal contracts from agencies such...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The delivery order, valued at $203,295.35, is for the supply of Illumina's proprietary sequencing instruments, reagents, and related products and services, to support the agency's genomic research and analysis needs. The contract has a...
This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and consumables. The $246,236.05 firm fixed price contract is for Illumina reagents and consumables, with no set-aside designation. Illumina has previously provided sequencing systems, reagents, and services to support genomic research and diagnostics across various...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $44,187.38 contract is for the provision of Illumina's sequencing systems, reagents, and related consumables and services to support genomic research and analysis activities. The contract has no set-aside designation and is not associated with a larger acquisition vehicle. Illumina, a manufacturer of genetic and...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $498,777.14 contract is to provide Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis for NHGRI's research and diagnostic needs. Illumina has been awarded multiple federal contracts and sub-grants by agencies such as the National...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $21,323.61 contract is for the provision of various Illumina sequencing systems, reagents, and related maintenance services to support genomic research and analysis across federal agencies. Illumina has a history of prime federal contract awards...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The $148,642.56 contract is for the provision of Illumina's proprietary sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. Illumina has a history of providing these types of products and services to various federal agencies through prime contract...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute, a component of the National Institutes of Health, to Illumina, Inc. for $138,338.85. The contract is not set aside and provides Illumina sequencing instruments, reagents, and other products to support genomic sequencing and analysis, which align with the National Human Genome Research Institute's mission to advance genomic medicine. Illumina has provided similar goods and services to other...
  • 75N92020D00022
    Indefinite Delivery Contract
  • 75N92020D00022-75N92020F00001
    Delivery Order

This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $229,042.26 firm fixed price award is for the delivery of Illumina reagents and consumables to support genomic sequencing and analysis at a location in San Diego, California. The contract has a performance period through September 2, 2025 and does not include any set-aside designations. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the NIH, CDC, USDA, and VA, to provide a range of sequencing instruments, reagents, and services in support of life science research, applied markets, and molecular diagnostics.

Generated 3/21/24, 10:29 PM